These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11837221)

  • 21. New Food and Drug Administration health claim requirements get mixed response.
    Brown D
    J Am Diet Assoc; 2005 Jan; 105(1):19-20. PubMed ID: 15635338
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 23. The one that got away.
    Nat Biotechnol; 2004 Jan; 22(1):1. PubMed ID: 14704684
    [No Abstract]   [Full Text] [Related]  

  • 24. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulator under siege.
    Wadman M
    Nature; 2007 Dec; 450(7173):1143. PubMed ID: 18097370
    [No Abstract]   [Full Text] [Related]  

  • 26. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 27. The need for increased oversight of genetic testing: a detailed look at the genetic testing process.
    Bonnin DC
    Houst J Health Law Policy; 2003; 4(1):149-80. PubMed ID: 16596751
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug trials bypass the elderly.
    Zoler ML
    Med World News; 1989 Mar; 30(6):29, 32. PubMed ID: 10292405
    [No Abstract]   [Full Text] [Related]  

  • 29. HHS, FDA announce new tools for the nutrition facts label.
    FDA Consum; 2007; 41(1):33. PubMed ID: 17342836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticipating REMS.
    Nat Rev Drug Discov; 2008 Dec; 7(12):963. PubMed ID: 19043440
    [No Abstract]   [Full Text] [Related]  

  • 31. Hard times at the FDA.
    Nat Immunol; 2005 Feb; 6(2):115. PubMed ID: 15662433
    [No Abstract]   [Full Text] [Related]  

  • 32. Compliance with Good Manufacturing Practices for facilities engaged in vector production, cell isolation, and genetic manipulations.
    Steel MP; Roessler BJ
    Curr Opin Biotechnol; 1999 Jun; 10(3):295-7. PubMed ID: 10361080
    [No Abstract]   [Full Text] [Related]  

  • 33. US watchdog finds bias against morning-after pill.
    Wadman M
    Nature; 2005 Nov; 438(7067):401. PubMed ID: 16306946
    [No Abstract]   [Full Text] [Related]  

  • 34. Public health. Strengthening the FDA.
    Friedman MA
    Science; 2002 Dec; 298(5602):2332. PubMed ID: 12493898
    [No Abstract]   [Full Text] [Related]  

  • 35. Tissue banking regulations and oversight.
    Eisenbrey AB; Frizzo W
    Clin Lab Med; 2005 Sep; 25(3):487-98. PubMed ID: 16129189
    [No Abstract]   [Full Text] [Related]  

  • 36. Indefinitely deferred: a look at blood donation policies for gay men.
    Smith B; Smith J
    N J Nurse; 2014 Apr; 44(2):4. PubMed ID: 24809166
    [No Abstract]   [Full Text] [Related]  

  • 37. Strengthening the regulation of clinical trials and bioresearch monitoring.
    FDA Consum; 2006; 40(6):35. PubMed ID: 17333566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug safety special: the safety catch.
    Wadman M
    Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591
    [No Abstract]   [Full Text] [Related]  

  • 39. No time for doomsday.
    Stetler CJ
    Hosp Formul; 1975 May; 10(5):220-1, 225-6. PubMed ID: 10237838
    [No Abstract]   [Full Text] [Related]  

  • 40. Reforming the food safety system: what if consolidation isn't enough?
    Harv Law Rev; 2007 Mar; 120(5):1345-66. PubMed ID: 17410681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.